These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 9551878
1. The antihypertensive effect and tolerability of candesartan cilexetil, a new generation angiotensin II antagonist, in comparison with losartan. Andersson OK, Neldam S. Blood Press; 1998 Jan; 7(1):53-9. PubMed ID: 9551878 [Abstract] [Full Text] [Related]
2. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring. Baguet JP, Nisse-Durgeat S, Mouret S, Asmar R, Mallion JM. Int J Clin Pract; 2006 Apr; 60(4):391-8. PubMed ID: 16620350 [Abstract] [Full Text] [Related]
3. Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators. Oparil S, Levine JH, Zuschke CA, Gradman AH, Ripley E, Jones DW, Hardison JD, Cushing DJ, Prasad R, Michelson EL. Am J Cardiol; 1999 Aug 01; 84(3):289-93. PubMed ID: 10496437 [Abstract] [Full Text] [Related]
4. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators. Lacourcière Y, Asmar R. Am J Hypertens; 1999 Dec 01; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580 [Abstract] [Full Text] [Related]
5. Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension. Oparil S. Am J Cardiol; 1999 Nov 18; 84(10A):35S-41S. PubMed ID: 10588093 [Abstract] [Full Text] [Related]
6. Antihypertensive treatment in elderly patients aged 75 years or over: a 24-week study of the tolerability of candesartan cilexetil in relation to hydrochlorothiazide. Neldam S, Forsén B, Multicentre Study Group. Drugs Aging; 2001 Nov 18; 18(3):225-32. PubMed ID: 11302289 [Abstract] [Full Text] [Related]
7. The efficacy and tolerability of candesartan cilexetil in an elderly hypertensive population. McInnes GT, O'Kane KP, Jonker J, Roth J. J Hum Hypertens; 1997 Sep 18; 11 Suppl 2():S75-80. PubMed ID: 9331015 [Abstract] [Full Text] [Related]
8. Candesartan cilexetil: comparison of once-daily versus twice-daily administration for systemic hypertension. Candesartan Cilexetil Study Investigators. Zuschke CA, Keys I, Munger MA, Carr AA, Marinides GN, Flanagan TL, Cushing DJ, Hayes JL, Michelson EL. Clin Ther; 1999 Mar 18; 21(3):464-74. PubMed ID: 10321416 [Abstract] [Full Text] [Related]
9. Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators. Reif M, White WB, Fagan TC, Oparil S, Flanagan TL, Edwards DT, Cushing DJ, Michelson EL. Am J Cardiol; 1998 Oct 15; 82(8):961-5. PubMed ID: 9794352 [Abstract] [Full Text] [Related]
10. Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group. Gradman AH, Lewin A, Bowling BT, Tonkon M, Deedwania PC, Kezer AE, Hardison JD, Cushing DJ, Michelson EL. Heart Dis; 1999 Oct 15; 1(2):52-7. PubMed ID: 11720604 [Abstract] [Full Text] [Related]
11. Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. Kloner RA, Weinberger M, Pool JL, Chrysant SG, Prasad R, Harris SM, Zyczynski TM, Leidy NK, Michelson EL, Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. Am J Cardiol; 2001 Mar 15; 87(6):727-31. PubMed ID: 11249891 [Abstract] [Full Text] [Related]
14. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring. Palma-Gamiz JL, Pêgo M, Marquez E, Pujol M, Olivan J, Alegría E, Sagastagoitia-Gorostiza JD, Gonzalez-Juanatey JR. Clin Drug Investig; 2007 Mar 15; 27(6):407-17. PubMed ID: 17506591 [Abstract] [Full Text] [Related]
15. A candesartan cilexetil/hydrochlorothiazide combination tablet provides effective blood pressure control in hypertensive patients inadequately controlled on monotherapy. Campbell M, Sonkodi S, Soucek M, Wiecek A. Clin Exp Hypertens; 2001 May 15; 23(4):345-55. PubMed ID: 11349825 [Abstract] [Full Text] [Related]
16. Tolerability of a modern antihypertensive agent: candesartan cilexetil. Andersson OK. Basic Res Cardiol; 1998 May 15; 93 Suppl 2():54-8. PubMed ID: 9833164 [Abstract] [Full Text] [Related]
17. Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients. McInnes GT, O'Kane KP, Istad H, Keinänen-Kiukaanniemi S, Van Mierlo HF. J Hum Hypertens; 2000 Apr 15; 14(4):263-9. PubMed ID: 10805052 [Abstract] [Full Text] [Related]